drugset / Trial / NCT01937871
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to see whether tadalafil can reduce the signs and symptoms in men with Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia-Lower Urinary Tract Symptoms (BPH-LUTS) and improve their quality of life.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-12
- Completion
- 2015-12
Outcome
Met primary endpoint
registry analysis (superiority or other test); Placebo vs 5 mg Tadalafil; Mean Difference (Final Values) -1.41 (95% CI -2.25 to -0.57) NCT01937871 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tadalafil | Small molecule | 5 mg | Oral |
| Subject | Tamsulosin | Other / unclassified | 0.2 mg | Oral |